Skip to content

iRadimed IRMD EV / sales

EV / sales at other companies

GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
2.1×-0.3×
Merit Medical Systems logo
Merit Medical SystemsMMSI
2.9×-1.9×
ICU Medical logo
ICU MedicalICUI
0.0×
ITG
Integer HoldingsITGR
2.4×-0.8×
AngioDynamics logo
AngioDynamicsANGO
1.4×+0.2×
Varex Imaging Corporation logo
Varex Imaging CorporationVREX
0.9×+0.2×

Other financials

Income statement

See full
Revenue$22.0M+12.6%
Gross profit$16.8M+13.3%
Operating income$7.2M+33.2%
Net income$5.8M+24.1%
EPS (diluted)$0.45+21.6%

Balance sheet

See full
Cash & equivalents$56.4M+12.0%
Total debt$59.2K-96.9%
Total equity$98.5M+9.4%
Total assets$114.4M+12.4%

Cash flow

See full
Operating cash flow$8.3M+93.2%
CapEx$403.0K-89.1%
Free cash flow$7.9M+1,226%

Valuation

See full
Market cap$1.2B+62.0%
P/E50.8×+13.4×
P/S13.9×+4.1×

Profitability

See full
Gross margin76.8%-0.1pp
Operating margin32.4%+2.3pp
Net margin27.4%+1.0pp
FCF margin28.4%+8.9pp

Returns & leverage

See full
Return on equity25%+1.2pp
Debt / equity0.0×
Current ratio7.1×-1.7×

Where this comes from

Calculated from iRadimed’s reported figures.

Based on the most recent quarter.

The official record: iRadimed’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about iRadimed's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is iRadimed's EV / sales?
iRadimed (IRMD) reported EV / sales of 8.2× in Q1 2025.
How has iRadimed's EV / sales changed year-over-year?
iRadimed's EV / sales increased by 8.1% year-over-year, from 7.6× to 8.2×.
What is the long-term trend for iRadimed's EV / sales?
Over 4 years (2020 to 2024), iRadimed's EV / sales has grown at a 4.5% compound annual growth rate (CAGR), from 7.4× to 8.8×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.